acid buffer (pH 3), and run at 1 mA/cm. The membrane was stained with 0.1% toluidine blue in 1% AcOH/50% EtOH.
Estimation of Apparent Molecular Weight
The apparent molecular weight of FG was estimated by HPLC analysis. The sample was applied on TSK GMPW XL gel filtration columns (7.6ϫ300 mmϫ2; Tosoh) and eluted with 0.1 M NaNO 3 at 0.6 ml/min at 40°C. Commercially available pullulans (Shodex P-52; Showa Denko, Tokyo, Japan) were used as standard molecular makers.
Determination of Pyruvate Content The amount of pyruvate was determined as follows: FG was hydrolyzed with 1 M trifluoroacetic acid (TFA) for 6 h at 120°C. After removal of TFA under N 2 gas, the hydrolysate was analyzed using a HPLC system equipped with UV detector at 220 nm. HPLC separation was performed using an Aminex HPX-87H column (7.8ϫ300 mm; Bio-Rad) at 40°C using 5 mM H 2 SO 4 (0.6 ml/min) as a mobile phase. The amount of pyruvate was calculated using a standard curve prepared with 0.08-10 mM sodium pyruvate.
Desulfation and Depyruvylation of FG Desulfation of FG was performed by solvolytic desulfation. 4) Briefly, FG (92 mg) was passed through a Dowex 50Wϫ8 resin (H ϩ form, 2ϫ13 cm) using H 2 O. After neutralization with pyridine, the solution was lyophilized. The resulting pyridinium salt of polysaccharide was dissolved in 10% MeOH/dimethyl sulfoxide (DMSO) (10 ml) and refluxed at 80°C for 5 h with continuous stirring. After exhaustive dialysis against H 2 O, the reaction mixture was lyophilized to yield desulfated FG (DSFG) (69 mg). DSFG was heated in 1% AcOH for 10 h in boiling water and the solution was neutralized with NaHCO 3 . After dialysis and lyophilization, depyruvylated DSFG (DSPFG) was obtained.
Chemical Analyses of Sulfated Galactan Uronic acid content was determined by the m-hydroxydiphenyl method. 5) Protein content was determined using a Bio-Rad protein assay kit. Sugar composition was determined as follows: FG was hydrolyzed with 2 M TFA at 120°C for 1 h. After removal of TFA under N 2 stream, the hydrolysates were converted to alditol acetates, which were analyzed by GC using an SP-2330 fused silica capillary column (30 mϫ0.32 mm i.d.: Supelco, Bellefonte, PA, U.S.A.) with an oven temperature of 220°C. Absolute configuration of monosaccharides was analyzed as (ϩ)-2-butyl-glycoside. 6) FG was converted to a triethylammonium salt (TEA-FG) as described by Stevenson and Furneaux 7) TEA-FG, DSFG and DSPFG were methylated by the Hakomori's method. 8) The methylated polysaccharides were treated with 90% formic acid for 1 h at 100°C and then hydrolyzed with 2 M TFA at 120°C for 1 h. Hydrolyzates were reduced with NaBH 4 and then acetylated. The partially methylated alditol acetates (PMAAs) were analyzed on GC using an SP-2330 fused silica capillary column and GC-MS using DB-5MS fused silica capillary column. Identification of PMAAs were carried out on the basis of retention times relative to 1,5-di-O-acetyl-2,3,4,6-tetra-Omethylglucitol and its mass fragmentation patterns.
NMR Analyses of Polysaccharide Polysaccharide (20 mg) was treated twice with D 2 O and re-dissolved in D 2 O. NMR spectra were recorded at 30 or 40°C on a ECX 400P spectrophotometer (JEOL) using internal DSS (sodium 2,2-dimethyl-2-silapentane-5-sulfonate) as reference. 1D ( 1 H and 13 C) and 2D double quantum filtered correlation spectroscopy (DQF-COSY), total correlation spectroscopy (TOCSY), nuclear Overhauser effect spectroscopy (NOESY), heteronuclear single quantum correlation (HSQC), HSQC-TOCSY, heteronuclear 2-bond correlation (H2BC), and heteronuclear multiple bonding correlation (HMBC)) experiments were performed.
Cells and Viruses Vero and Madin-Darby canine kidney (MDCK) cells were grown in MEM containing 5% fetal bovine serum (FBS). HSV-2 (UW268 strain) and influenza A virus (A/NWS/33, H1N1) (IFV-A) were propagated on Vero and MDCK cells, respectively.
Evaluation for Antiviral Activity and Cytotoxicity in Vitro For cell growth inhibition studies, Vero and MDCK cells were cultured for 72 h in the presence of increasing amounts of FG. Viable cell yield was determined by the trypan blue exclusion test. The inhibition data were plotted as dose-response curves, from which the 50% cell growth inhibitory concentration (CC 50 ) was obtained. For antiviral tests, cell monolayers in 48 well plates were infected with virus at 0.1 plaque-forming unit (PFU) per cell at room temperature. After 1 h of viral infection, the monolayers were washed three times with phosphate-buffered saline (PBS) and incubated in maintenance medium (MEM plus 2% FBS) at 37°C. Samples were added during infection and throughout the incubation thereafter, or immediately after virus infection. The cell cultures were harvested at 24 h post-infection (p.i.), and their virus yields were determined by plaque assay after 2 d of incubation. The antiviral activity was expressed as the 50% inhibitory concentration (IC 50 ), which was the concentration of sample that reduced plaque numbers by 50% in the treated cultures as compared with no drug control.
Time-of-Addition Experiment Vero cell monolayers were infected with HSV-2 at 10 PFU per cell. FG was added at a concentration of 100 mg/ml before viral infection for 3 h, during viral infection for 1 h, during viral infection and throughout the incubation thereafter, immediately after infection, at 1 h p.i., at 3 h p.i., or at 6 h p.i. At 24 h p.i., the cell cultures were harvested and subjected to plaque assay.
Virus Adsorption Assay The effect of FG on HSV-2 adsorption to host cells was evaluated by an infectious center assay. 9) Briefly, Vero cell suspensions, HSV-2 (1 PFU/cell) and FG were pre-cooled on ice for 3 h before mixing at 4°C. After 1 h incubation at 4°C, the cell suspensions were washed three times with ice-cold PBS to remove any unbound viruses and free compounds. The cell pellets were diluted 10-fold with ice-cold PBS and immediately added to Vero cell monolayers in 35-mm dishes to be plaque-assayed.
Virus Penetration Assay Virus penetration into host cells was evaluated according to the method reported by Huang and Wagner 10) with some modifications. Vero cell monolayers in 12-well plates pre-cooled for 3 h on ice were infected with HSV-2 (approximately 100 PFU/well) at 4°C for 1 h in the absence of compound. After washing three times with ice-cold PBS, cell monolayers were incubated at 37°C in the media containing FG. At 0, 0.5, 1, 2, 3, and 6 h after the temperature shift to 37°C, the cell monolayers were treated with a 40 mM citrate buffer (pH 3.0) for 1 min to inactivate any unpenetrated viruses, and then overlaid with media containing 0.8% methylcellulose and 2% FBS to be plaqueassayed.
Virucidal Assay
To determine the effect of FG on direct inactivation of virus particles, HSV-2 (2ϫ10 4 PFU/100 ml) was treated with an equal volume of FG at 37°C. After 0, 1, 2, 3, or 6 h, 100-fold dilutions of the mixture were added to Vero cell monolayers for 1 h at room temperature. The cell monolayers were overlaid with media containing 0.8% methylcellulose and 2% FBS to be plaque-assayed.
Evaluation for Anti-HSV-2 Activity in Vivo Female BALB/c mice (5-6 weeks old) were obtained from Japan SLC, Shizuoka, Japan. All experiments were conducted in accordance with the animal experimentation guidelines of the University of Toyama. Mice were subcutaneously injected with 3 mg medroxyprogesterone 17-acetate at 6 d and 1 d before virus inoculation, and then were infected vaginally with HSV-2 (1ϫ10 5 PFU). FG (1 mg/20 ml) or ACV (0.2 or 1 mg/20 ml) was administered intra-vaginally 5 times, that is, 1 h before infection, 10 min, 6 h, 24 h and 48 h after infection. In the control group, mice were treated with 20 ml PBS. Clinical signs of infection were graded according to a five-point scale: 0, no sign of infection; 1, slight genital erythema and edema; 2, moderate genital inflammation; 3, severe exudative genital lesion; 4, hind limb paralysis; and 5, death. Viral shedding was determined by washing the vaginal cavity with 100 ml PBS on day 3 after infection and titrating the virus on Vero cell monolayers.
Statistical Analysis The data are presented as the meanϮS.D. The differences between groups were analyzed by one-way analysis of variance (ANOVA), and correction for multiple comparisons was made by using Dunnett's multiple-comparison test. A comparison between the two groups was made by using Student's t-test.
RESULTS

Isolation of Sulfated Galactan from Codium fragile
The defatted algal powder, obtained by treatment with EtOH, was extracted with hot water to give hot-water extract (F). Non-dialyzable portion (FH) was subjected to a DEAE 650M anion exchange column chromatography with a linear gradient elution to give four fractions (FH-1 to -4). The most abundant fraction (FH-4) was subjected to gel filtration on Sepharose 6B, and it gave four fractions. The most abundant fraction (FH-4C) was re-chromatographed to give sulfated galactan (FG). FG was detected as a single band on the cellulose acetate membrane electrophoresis and eluted as a single and symmetrical peak on analytical HPLC (Fig. 1 ). Therefore, FG was regarded to be a highly purified polysaccharide. Its molecular weight (Mw) was estimated to be 1.4ϫ10 5 (Mw/Mnϭ1.17) by HPLC analysis.
Chemical Characterization of FG Sugar composition analysis revealed that FG consisted of large amounts of galactose (98%) with trace amounts of arabinose (2%). The galactose residues were identified to be D-configurations by comparing with authentic D-and L-galactoses after derivatization to corresponding (ϩ)-2-butyl galactosides. A trace amount of protein and uronic acid in FG were detected by using a Bradford assay and m-hydroxydiphenyl method. The IR spectrum of FG contained an intense absorption band at 1257 cm Ϫ1 which is common to the sulfate esters, therefore, FG was suggested to be a sulfated polysaccharide. Furthermore, the presence of a sulfate absorption band at 848 cm Ϫ1 (secondary axial sulfate) indicated that the majority of sulfate groups occupy the 4-O of galactose residues. Since the sulfur content was found to be 4.4% by elemental analysis, the sulfate content of FG was calculated to be 11%. On the other hand, carboxylic acid stretching absorption (1645 cm Ϫ1 ) was observed in its IR spectrum. In addition, singlet methyl signal (1.68 ppm) was also observed in its 1 H-NMR spectrum. Therefore, it was suggested that FG carried another functional group such as pyruvate ketal ester in the polymer, and pyruvate content was estimated to be 12.3% by HPLC analysis.
In order to determine the sugar linkages and the position of substituents, FG was subjected to solvolytic desulfation to obtain desulfated FG (DSFG). Pyruvate esters were removed by weak acid hydrolysis to give desulfated and depyruvated FG (DSPFG). As shown in Table 1 , methylation of DSFG revealed that it mainly consisted of Galp-(1→, →3)-Galp-(1→ and →3,6)-Galp-(1→. On the other hand, DSFG was suggested to be composed of 3-substituted, 3,4-disubstiuted and 3,6-disubstituted galactose residue. Therefore, pyruvic acid residue was suggested to be present at 3-O-and 4-O-positions of nonreducing terminal galactose residue. Furthermore, it was found that FG was composed of 3-substituted, 3,4-disubstituted and 3,4,6-trisubstituted galactose residue. On comparing data of methylation analyses of FG and DSFG, 3,4-and 3,4,6-substituted residues were increased, 894 Vol. 32, No. 5 whereas, 3-substituted residue was decreased. Therefore, sulfate esters were suggested to be present at 4-O-positions of →3)-Galp-(1→ and →3,6)-Galp-(1→ residues. NMR Analyses of DSPFG and DSFG In general, sulfate substitutions cause signal broadening and perturbation of the substitution pattern which give complicated spectrum. As shown in Fig. 2 , DSPFG (a) gave more simple Table 2 . When 13 C chemical shifts of residues A, B and C were compared with those of methyl-b-D-galactopyranoside, significant downfield shifts were observed at C-3 of residues A and C (data not shown). Thus, these residues were suggested to be substituted at O-3 position at the residues. Additionally, C-6 signal (d 72.4) of residue C was also deshielded and it indicated that the residue C was disubstituted residue at O-3 and O-6 positions.
On the other hand, three extra carbon signals at d 26.1, d 110.5, and d 180.2 were observed in the DSFG when compared with that of DSPFG (Fig. 2) . Therefore, these signals were suggested to be originated from pyruvate ester and their chemical shifts were consistent with those of literatural data. 11, 12) In addition, chemical shifts of residues B, which was assigned to be a non-reducing terminal residue, was solely changed when compared with those of DSPFG ( Table  2 ). In particular, C-3 and C-4 were shifted downfield which suggests that the pyruvate was substituted at these positions (Fig. 3) . In addition, HMBC correlation between d H 4.21 and d C 110.5 revealed the presence of long-range coupling between H-3 of residue B and quaternary carbon in pyruvate group. By combining the data of methylation analyses, pyruvate was suggested to be present as a five-membered cyclic ketal including O-3 and O-4 of the non-reducing terminal galactose residues.
The sequence of glycosyl residues of DSPFG was determined by NOESY and HMBC experiments. NOE and HMBC correlations between H-1 (d 4.68) and H-3 (d 3.84)/C-3 (d 84.7) of residue A were observed and the residue was suggested to be linked at O-3 of the adjacent Antiviral Activities of FG The antiviral potency of FG was evaluated against HSV-2 and IFV-A and shown at Table  3 . Cytotoxicities of FG were quite low, with CC 50 values of 3700 and 4300 mg/ml for Vero and MDCK cells, respectively. The IC 50 values for HSV-2 and IFV-A replication were 4.7 and Ͼ1000 mg/ml, respectively, under conditions in which the polysaccharide was added at the same time as viral infection (experiment A). The resulting selectivity indices (SI, CC 50 /IC 50 ) were 790 and Ͻ4 for HSV-2 and IFV-A, respectively. Therefore, it was suggested that FG had a potent anti-HSV-2 effect whereas it did not possess anti-IFV-A effect. In addition, FG showed anti-HSV-2 activity when it was added after viral infection (experiment B). However, the value of SI was lower than that in experiment A. These experimental results suggested that antiviral target(s) of FG might be the inhibition of virus binding and/or penetration step(s) onto the host cells.
In order to delineate the most sensitive phase of HSV-2 replication to FG, time-of-addition experiments were performed. In these experiments, Vero cells were infected with HSV-2 at a high multiplicity of infection of 10. As shown in Fig. 4 , FG suppressed virus production most efficiently when added at the same time as virus infection and throughout the incubation thereafter. On the other hand, pretreatment of host cells with FG showed no inhibitory effects, and less anti-HSV-2 effect was observed when added to the medium only during viral infection. It is noteworthy that FG maintained antiviral activity at higher levels when added to the medium even after 6 h of virus infection.
From the results of the time-of-addition experiments as described above, the most sensitive phase of HSV-2 replication to FG was suggested to be the very early events: virus adsorption to the host cell surface and/or virus penetration into host cells. At first, the effect of FG on HSV-2 adsorption into host cells was evaluated by an infectious center assay, which determined the number of cells binding the virus particles at low temperature (4°C) in the presence of different concentrations of the compound. As shown in Fig. 5a , FG showed a concentration-dependent interference with virus adsorption. Therefore, one of the antiviral targets of FG was suggested to be the interference of virus-cell interaction. An additional study investigated whether or not FG inhibited the virus penetration into host cells or not, since the virus penetration process was one possible target of FG. As shown in Fig. 5b , FG also showed the inhibitory effects on virus penetration in a concentration-dependent manner. Therefore, it was suggested that the virus penetration step was also involved in the antiviral target of FG.
As described above, while main antiviral target(s) of FG was suggested to be early stage(s) of HSV-2 replication, there are possibilities to possess another antiviral mechanism since FG showed antiviral effects by its addition to the medium after 6 h post infection when virus binding and penetration steps had completed (Fig. 4) . If FG could exert virucidal effect on progeny viruses released from infected cells, this effect might contribute to the antiviral activity of delayed addition of the compound. Thus, we attempted to elucidate whether FG had the effect on HSV inactivation or not. As shown in Fig. 6 , preincubation of HSV-2 with FG resulted in time-and concentration-dependent reduction of remaining infectivity. For example, the remaining infectivity was reduced to 42% and 5.8% of the no-drug control by 2-and 6-h 896 Vol. 32, No. 5 a) Sample was added to the medium during infection and throughout the incubation. b) Sample was added to the medium immediately after viral infection. treatment, respectively, with FG at 10 mg/ml.
Effect of FG on Experimental Genital Herpetic Infection In order to investigate whether FG could protect mice from HSV-2 infection, the animals pretreated with medroxyprogesterone were given FG intravaginally 5 times beginning 1h before vaginal challenge with the virus. No toxicity was observed due to the administration of the compound. The mean titers of virus shed on day 3 were reduced from 17.5ϫ10
2 PFU/100 ml in untreated control mice to 0.66ϫ10 2 , 1.1ϫ10 2 and 0.26ϫ10 2 PFU/100 ml in mice that received 1 mg FG (pϽ0.05), 0.2 mg (pϽ0.05) and 1 mg (pϽ0.05) ACV, respectively (Fig. 7a) . The mice treated with FG also showed significantly suppressed herpetic lesions as compared with untreated ones (Fig. 7b) . As predicted from viral shedding and severity of infection, all mice (5/5) treated with FG and ACV (1 mg/20 ml) survived the virus challenge, while 60 (3/5) and 40 (2/5) % of mice untreated or treated with ACV (0.2 mg/20 ml), respectively, died by day 10 after infection ( Fig. 7c) .
DISCUSSION
In the present study, we isolated a sulfated galactan (FG) from C. fragile possessing anti-HSV-2 activity in vitro and in vivo. FG consisted of a large amount of galactose residues with trace arabinose, and the presence of pyruvate and sulfate as substituents were observed. Chemical and spectroscopic analyses revealed that FG consisted of b-D-Galp-(1→, →3)-b-D-Galp-(1→ and →3,6)-b-D-Galp-(1→ with a ratio of ca. 2 : 3 : 2. Together with these residues, a small amount of →6)-Galp-(1→ and →3,4)-Galp-(1→ residues was also detected on methylation analysis. In addition, sulfates were suggested to be mainly linked at O-4 of →3)-Galp-(1→ and →3,6)-Galp-(1→ residues on the basis of the results of methylation analyses. Also, FG was suggested to be highly branched, and 3-O-and 4-O-positions of non-reducing termini were masked by 3,4-O-(1Ј-carboxy)-ethylidene cyclic ketal. By considering the biosynthesis of polysaccharides, the pyruvic acid ketals were suggested to block the chain elongation in the biosynthesis of FG. So far, sulfated galactans have been isolated from Codium sp. such as C. yezoense and C. isthmocladum. 11, 12) Our study revealed that structural features of FG was closely resembled those of sulfated galactan from C. yezoense. However, 4,6-O-(1Ј-carboxy)-ethylidene cyclic ketal was not present in the case of FG as reported by previous report.
11) Furthermore, Ciancia et al. reported that sulfated galactan or sulfated arabinogalactan was extracted from C. fragile. 13) The polysaccharide is composed of 3-linked b-D-galactopyranose and it is highly sulfated and substituted with pyruvic acid ketals, however, detailed structure is still unknown. Therefore, this paper is the first report concerning the isolation and determination of the fine chemical structure of sulfated galactan from C. fragile.
To date there are several studies on biological activities of sulfated polysaccharides from Codium sp., such as anticoagulant activity, induction of platelet aggregation, antiangiogenesis and antiviral activities. [13] [14] [15] [16] [17] [18] However, the antiviral effect of galactan sulfates from Codium sp. have not been reported previously. In the present study, it was shown that FG possesses antiviral activity against HSV-2. The mechanisms by which sulfated polysaccharides inhibit can be explained in general by the inhibition of virus binding to host cells and subsequent virus-cell fusion step. 19) The main antiviral target of FG was also found to be the interference of virus-host cell interaction such as virus binding and penetration steps (Figs.  4, 5 ). In addition, FG was found to make the virion to lose its infectivity (Fig. 6 ). So far, there are several reports that some sulfated polysaccharides such as l-carrageenan from Gigartina skottsbergii (1T1) exerted virucidal effect. 20) In general, the virucidal effect is thought to be favorable in preventing from virus infection. In the present study, in vivo anti-HSV-2 effect of FG was evaluated using HSV-2 genital infection model. The high therapeutic efficacy of FG was confirmed in this murine model (Fig. 7) . The in vivo anti-HSV-2 effect of FG might reflect its in vitro antiviral actions exerted by the interference of viral attachment and virucidal activity. 
